Upregulation of the leptin-leptin receptor axis has been shown to contribute to the pathogenesis of pulmonary arterial hypertension in humans and to experimental hypoxia-induced pulmonary hypertension in rats [8,9]. The gene discussed is LEPR; the disease is pulmonary arterial hypertension.